| 0 |
PREMATURE OVULATION |
41 |
0.5256 |
| 1 |
ASSISTED REPRODUCTIVE TECHNOLOGY |
1 |
0.5000 |
| 2 |
PAROVARIAN CYST |
1 |
0.1000 |
| 3 |
BLOOD LUTEINISING HORMONE INCREASED |
17 |
0.0691 |
| 4 |
OVARIAN HYPERSTIMULATION SYNDROME |
136 |
0.0583 |
| 5 |
VERTEBROBASILAR ARTERY DISSECTION |
5 |
0.0568 |
| 6 |
OVARIAN TORSION |
3 |
0.0361 |
| 7 |
PERITONEAL FLUID ANALYSIS ABNORMAL |
3 |
0.0341 |
| 8 |
NONINFECTIVE OOPHORITIS |
2 |
0.0299 |
| 9 |
BLOOD OESTROGEN INCREASED |
15 |
0.0255 |
| 10 |
OVARIAN HAEMORRHAGE |
6 |
0.0253 |
| 11 |
VACCINATION SITE MASS |
1 |
0.0244 |
| 12 |
PROGESTERONE ABNORMAL |
1 |
0.0222 |
| 13 |
MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE |
3 |
0.0195 |
| 14 |
IMMINENT ABORTION |
1 |
0.0182 |
| 15 |
HUMAN CHORIONIC GONADOTROPIN ABNORMAL |
1 |
0.0172 |
| 16 |
FAILED IN VITRO FERTILISATION |
1 |
0.0164 |
| 17 |
HETEROTOPIC PREGNANCY |
1 |
0.0159 |
| 18 |
OVARIAN NECROSIS |
1 |
0.0159 |
| 19 |
RETT SYNDROME |
1 |
0.0156 |
| 20 |
OESTRADIOL ABNORMAL |
1 |
0.0152 |
| 21 |
BORDERLINE OVARIAN TUMOUR |
1 |
0.0149 |
| 22 |
ENDOTOXIC SHOCK |
1 |
0.0145 |
| 23 |
PELVIC FLUID COLLECTION |
10 |
0.0142 |
| 24 |
OVARIAN ENLARGEMENT |
5 |
0.0131 |
| 25 |
INGUINAL HERNIA, OBSTRUCTIVE |
1 |
0.0125 |
| 26 |
POLYNEUROPATHY IN MALIGNANT DISEASE |
1 |
0.0122 |
| 27 |
CERVIX CERCLAGE PROCEDURE |
1 |
0.0122 |
| 28 |
OVARIAN DISORDER |
11 |
0.0117 |
| 29 |
UTERINE TENDERNESS |
1 |
0.0116 |
| 30 |
HAEMOCONCENTRATION |
2 |
0.0116 |
| 31 |
PROCEDURAL FAILURE |
2 |
0.0112 |
| 32 |
ADNEXAL TORSION |
3 |
0.0095 |
| 33 |
BIOCHEMICAL PREGNANCY |
1 |
0.0093 |
| 34 |
URETERIC INJURY |
1 |
0.0089 |
| 35 |
LABOUR COMPLICATION |
2 |
0.0085 |
| 36 |
TWIN PREGNANCY |
7 |
0.0083 |
| 37 |
TUBO-OVARIAN ABSCESS |
2 |
0.0082 |
| 38 |
DYSACUSIS |
1 |
0.0081 |
| 39 |
RESPIRATORY TRACT MALFORMATION |
1 |
0.0075 |
| 40 |
DELAYED DELIVERY |
1 |
0.0070 |
| 41 |
POSTMATURE BABY |
1 |
0.0068 |
| 42 |
SHORTENED CERVIX |
2 |
0.0068 |
| 43 |
PELVIC HAEMATOMA |
3 |
0.0068 |
| 44 |
PERITONEAL HAEMORRHAGE |
9 |
0.0065 |
| 45 |
PROGESTERONE DECREASED |
2 |
0.0064 |
| 46 |
ENTEROBACTER PNEUMONIA |
1 |
0.0064 |
| 47 |
PROLONGED PREGNANCY |
1 |
0.0064 |
| 48 |
BLADDER INJURY |
2 |
0.0063 |
| 49 |
MORPHOEA |
3 |
0.0062 |
| 50 |
ABORTION THREATENED |
3 |
0.0060 |
| 51 |
SUSPECTED PRODUCT QUALITY ISSUE |
11 |
0.0060 |
| 52 |
ANAEMIA OF PREGNANCY |
1 |
0.0058 |
| 53 |
SUBCHORIONIC HAEMATOMA |
1 |
0.0057 |
| 54 |
BLOOD LUTEINISING HORMONE DECREASED |
1 |
0.0056 |
| 55 |
MULTIPLE PREGNANCY |
1 |
0.0056 |
| 56 |
IN VITRO FERTILISATION |
1 |
0.0055 |
| 57 |
CERVIX HAEMORRHAGE UTERINE |
1 |
0.0052 |
| 58 |
HEART VALVE CALCIFICATION |
1 |
0.0050 |
| 59 |
ANOVULATORY CYCLE |
1 |
0.0048 |
| 60 |
VACCINATION SITE ERYTHEMA |
1 |
0.0046 |
| 61 |
FEMALE REPRODUCTIVE TRACT DISORDER |
1 |
0.0046 |
| 62 |
CONGENITAL HEART VALVE DISORDER |
1 |
0.0042 |
| 63 |
AMNIOTIC CAVITY INFECTION |
3 |
0.0041 |
| 64 |
CERVICAL INCOMPETENCE |
2 |
0.0039 |
| 65 |
EFFUSION |
5 |
0.0037 |
| 66 |
GAMMA-GLUTAMYLTRANSFERASE ABNORMAL |
2 |
0.0033 |
| 67 |
ECTOPIC PREGNANCY |
10 |
0.0032 |
| 68 |
DRUG EXPOSURE BEFORE PREGNANCY |
3 |
0.0030 |
| 69 |
VASCULAR STENOSIS |
1 |
0.0029 |
| 70 |
THYROXINE INCREASED |
2 |
0.0028 |
| 71 |
ARTERIAL THROMBOSIS |
5 |
0.0026 |
| 72 |
RUPTURED ECTOPIC PREGNANCY |
2 |
0.0026 |
| 73 |
PLACENTA PRAEVIA |
2 |
0.0025 |
| 74 |
AMAUROSIS |
2 |
0.0024 |
| 75 |
THREATENED LABOUR |
1 |
0.0023 |
| 76 |
ALLERGY TEST POSITIVE |
1 |
0.0022 |
| 77 |
PREMENSTRUAL SYNDROME |
3 |
0.0022 |
| 78 |
NECROSIS ISCHAEMIC |
1 |
0.0022 |
| 79 |
URINARY TRACT PAIN |
1 |
0.0020 |
| 80 |
DRUG LEVEL DECREASED |
20 |
0.0020 |
| 81 |
OVARIAN FAILURE |
1 |
0.0019 |
| 82 |
ARRHYTHMIA SUPRAVENTRICULAR |
2 |
0.0018 |
| 83 |
LYMPHOCYTE MORPHOLOGY ABNORMAL |
1 |
0.0017 |
| 84 |
PROLONGED LABOUR |
1 |
0.0016 |
| 85 |
HYDROPS FOETALIS |
1 |
0.0016 |
| 86 |
TOXIC SHOCK SYNDROME |
1 |
0.0016 |
| 87 |
ABORTION MISSED |
2 |
0.0016 |
| 88 |
ADNEXA UTERI PAIN |
2 |
0.0016 |
| 89 |
GESTATIONAL HYPERTENSION |
2 |
0.0015 |
| 90 |
CYTOKINE STORM |
1 |
0.0015 |
| 91 |
PRERENAL FAILURE |
2 |
0.0014 |
| 92 |
FOETAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0014 |
| 93 |
QRS AXIS ABNORMAL |
1 |
0.0013 |
| 94 |
BREAST FEEDING |
1 |
0.0013 |
| 95 |
GENERALISED TONIC-CLONIC SEIZURE |
21 |
0.0013 |
| 96 |
PLACENTAL INSUFFICIENCY |
1 |
0.0012 |
| 97 |
HEAT EXHAUSTION |
1 |
0.0012 |
| 98 |
SUPERFICIAL VEIN THROMBOSIS |
1 |
0.0012 |
| 99 |
ABSCESS DRAINAGE |
1 |
0.0012 |
| 100 |
HYPERLEUKOCYTOSIS |
1 |
0.0011 |
| 101 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
1 |
0.0011 |
| 102 |
HUMAN CHORIONIC GONADOTROPIN INCREASED |
1 |
0.0011 |
| 103 |
CONDUCTION DISORDER |
2 |
0.0011 |
| 104 |
GESTATIONAL DIABETES |
5 |
0.0010 |
| 105 |
CROSS SENSITIVITY REACTION |
1 |
0.0010 |
| 106 |
MUCOSAL DISORDER |
1 |
0.0010 |
| 107 |
UTERINE PAIN |
1 |
0.0010 |
| 108 |
ABORTION SPONTANEOUS |
39 |
0.0010 |
| 109 |
BREAST DISCOMFORT |
1 |
0.0010 |
| 110 |
UTERINE CONTRACTIONS DURING PREGNANCY |
1 |
0.0010 |
| 111 |
POSTICTAL STATE |
1 |
0.0010 |
| 112 |
CYTOGENETIC ANALYSIS ABNORMAL |
1 |
0.0010 |
| 113 |
ASCITES |
28 |
0.0010 |
| 114 |
VASCULAR CALCIFICATION |
1 |
0.0009 |
| 115 |
IMMEDIATE POST-INJECTION REACTION |
1 |
0.0009 |
| 116 |
PREMATURE LABOUR |
5 |
0.0009 |
| 117 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
6 |
0.0009 |
| 118 |
HAEMATOCRIT INCREASED |
2 |
0.0009 |
| 119 |
INTRA-ABDOMINAL HAEMORRHAGE |
2 |
0.0008 |
| 120 |
PREMATURE RUPTURE OF MEMBRANES |
2 |
0.0008 |
| 121 |
INTRA-ABDOMINAL HAEMATOMA |
1 |
0.0008 |
| 122 |
BLADDER DISCOMFORT |
1 |
0.0008 |
| 123 |
VAGINAL ODOUR |
1 |
0.0008 |
| 124 |
TRISOMY 21 |
1 |
0.0008 |
| 125 |
IATROGENIC INJURY |
1 |
0.0008 |
| 126 |
FOETAL DEATH |
4 |
0.0008 |
| 127 |
ABDOMINAL OPERATION |
1 |
0.0008 |
| 128 |
ABDOMINAL MASS |
2 |
0.0007 |
| 129 |
IMMUNOGLOBULINS DECREASED |
1 |
0.0007 |
| 130 |
INTENSIVE CARE |
1 |
0.0007 |
| 131 |
HAEMORRHAGE IN PREGNANCY |
1 |
0.0007 |
| 132 |
HAEMOTHORAX |
2 |
0.0007 |
| 133 |
CAESAREAN SECTION |
8 |
0.0007 |
| 134 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
2 |
0.0007 |
| 135 |
INJECTION SITE PARAESTHESIA |
1 |
0.0007 |
| 136 |
POLYCYSTIC OVARIES |
1 |
0.0006 |
| 137 |
NEONATAL DISORDER |
1 |
0.0006 |
| 138 |
LOW BIRTH WEIGHT BABY |
5 |
0.0006 |
| 139 |
INTRA-UTERINE DEATH |
1 |
0.0006 |
| 140 |
PITUITARY TUMOUR BENIGN |
1 |
0.0006 |
| 141 |
RENAL CELL CARCINOMA |
3 |
0.0006 |
| 142 |
GAZE PALSY |
1 |
0.0006 |
| 143 |
JUGULAR VEIN THROMBOSIS |
1 |
0.0006 |
| 144 |
UTERINE POLYP |
1 |
0.0006 |
| 145 |
CEREBRAL VENOUS THROMBOSIS |
1 |
0.0006 |
| 146 |
HYDROCEPHALUS |
3 |
0.0006 |
| 147 |
HYPOMANIA |
2 |
0.0005 |
| 148 |
PUPILLARY REFLEX IMPAIRED |
1 |
0.0005 |
| 149 |
RETINOPATHY |
2 |
0.0005 |
| 150 |
JAUNDICE NEONATAL |
1 |
0.0005 |
| 151 |
PRODUCT STORAGE ISSUE |
2 |
0.0005 |
| 152 |
PREGNANCY |
10 |
0.0005 |
| 153 |
CAPILLARY LEAK SYNDROME |
1 |
0.0005 |
| 154 |
GASTROINTESTINAL PERFORATION |
2 |
0.0005 |
| 155 |
URINARY BLADDER HAEMORRHAGE |
1 |
0.0005 |
| 156 |
BIPOLAR I DISORDER |
1 |
0.0005 |
| 157 |
INJECTION SITE URTICARIA |
11 |
0.0004 |
| 158 |
PELVIC PAIN |
8 |
0.0004 |
| 159 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
2 |
0.0004 |
| 160 |
HAEMANGIOMA |
1 |
0.0004 |
| 161 |
ABORTION INDUCED |
4 |
0.0004 |
| 162 |
PULMONARY INFARCTION |
1 |
0.0004 |
| 163 |
DIABETES INSIPIDUS |
1 |
0.0004 |
| 164 |
ABNORMAL UTERINE BLEEDING |
1 |
0.0004 |
| 165 |
HEPATOSPLENOMEGALY |
1 |
0.0004 |
| 166 |
ANAESTHETIC COMPLICATION |
1 |
0.0004 |
| 167 |
BREAST SWELLING |
1 |
0.0004 |
| 168 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 169 |
INVASIVE DUCTAL BREAST CARCINOMA |
1 |
0.0004 |
| 170 |
PLEURITIC PAIN |
1 |
0.0004 |
| 171 |
NECROSIS |
2 |
0.0004 |
| 172 |
LUNG CONSOLIDATION |
1 |
0.0004 |
| 173 |
PRODUCT LEAKAGE |
2 |
0.0004 |
| 174 |
OESOPHAGEAL STENOSIS |
1 |
0.0004 |
| 175 |
POST PROCEDURAL HAEMORRHAGE |
4 |
0.0003 |
| 176 |
DRUG EXPOSURE DURING PREGNANCY |
11 |
0.0003 |
| 177 |
INJECTION SITE HYPERSENSITIVITY |
1 |
0.0003 |
| 178 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 179 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0003 |
| 180 |
MANIA |
5 |
0.0003 |
| 181 |
OVARIAN CYST |
3 |
0.0003 |
| 182 |
HEPATIC CYST |
1 |
0.0003 |
| 183 |
INJECTION SITE RASH |
9 |
0.0003 |
| 184 |
VIITH NERVE PARALYSIS |
1 |
0.0003 |
| 185 |
ABDOMINAL DISTENSION |
30 |
0.0003 |
| 186 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 187 |
HYPERACUSIS |
1 |
0.0003 |
| 188 |
BREAST TENDERNESS |
2 |
0.0003 |
| 189 |
MATERNAL DRUGS AFFECTING FOETUS |
2 |
0.0003 |
| 190 |
PULMONARY HAEMORRHAGE |
2 |
0.0003 |
| 191 |
VENOUS THROMBOSIS |
1 |
0.0003 |
| 192 |
AFFECTIVE DISORDER |
2 |
0.0003 |
| 193 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 194 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 195 |
INJURY ASSOCIATED WITH DEVICE |
5 |
0.0002 |
| 196 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 197 |
LIVE BIRTH |
2 |
0.0002 |
| 198 |
UTERINE HAEMORRHAGE |
1 |
0.0002 |
| 199 |
FACIAL PARALYSIS |
2 |
0.0002 |
| 200 |
TENSION HEADACHE |
1 |
0.0002 |
| 201 |
VULVOVAGINAL DISCOMFORT |
1 |
0.0002 |
| 202 |
INJECTION SITE PRURITUS |
15 |
0.0002 |
| 203 |
GASTROINTESTINAL INFECTION |
2 |
0.0002 |
| 204 |
PAPILLOEDEMA |
1 |
0.0002 |
| 205 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 206 |
OPTIC NEURITIS |
2 |
0.0002 |
| 207 |
URINE ABNORMALITY |
1 |
0.0002 |
| 208 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 209 |
INJECTION SITE PAPULE |
1 |
0.0002 |
| 210 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 211 |
TUMOUR MARKER INCREASED |
1 |
0.0002 |
| 212 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 213 |
NEEDLE ISSUE |
6 |
0.0002 |
| 214 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 215 |
SMALL FOR DATES BABY |
1 |
0.0002 |
| 216 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 217 |
HYPOTONIA |
2 |
0.0002 |
| 218 |
PREMATURE BABY |
6 |
0.0002 |
| 219 |
PRODUCT SOLUBILITY ABNORMAL |
1 |
0.0002 |
| 220 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 221 |
PETECHIAE |
2 |
0.0002 |
| 222 |
CATATONIA |
1 |
0.0002 |
| 223 |
NYSTAGMUS |
1 |
0.0002 |
| 224 |
INTESTINAL RESECTION |
1 |
0.0002 |
| 225 |
NORMAL NEWBORN |
1 |
0.0002 |
| 226 |
DEAFNESS UNILATERAL |
1 |
0.0002 |
| 227 |
PLEURAL EFFUSION |
11 |
0.0002 |
| 228 |
INTERMENSTRUAL BLEEDING |
1 |
0.0002 |
| 229 |
HYPERVENTILATION |
1 |
0.0002 |
| 230 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 231 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 232 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 233 |
OLIGURIA |
1 |
0.0002 |
| 234 |
SWELLING OF EYELID |
1 |
0.0002 |
| 235 |
MATERNAL EXPOSURE DURING PREGNANCY |
14 |
0.0002 |
| 236 |
MYDRIASIS |
2 |
0.0002 |
| 237 |
INCOHERENT |
1 |
0.0002 |
| 238 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
1 |
0.0002 |
| 239 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 240 |
ANKYLOSING SPONDYLITIS |
2 |
0.0002 |
| 241 |
MENINGITIS |
1 |
0.0001 |
| 242 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 243 |
NEPHROTIC SYNDROME |
1 |
0.0001 |
| 244 |
SINUS TACHYCARDIA |
2 |
0.0001 |
| 245 |
FEAR OF INJECTION |
1 |
0.0001 |
| 246 |
VAGINAL HAEMORRHAGE |
6 |
0.0001 |
| 247 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 248 |
ORAL DISORDER |
1 |
0.0001 |
| 249 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 250 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 251 |
DRUG INTERACTION |
21 |
0.0001 |
| 252 |
INJECTION SITE SWELLING |
10 |
0.0001 |
| 253 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 254 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 255 |
INJECTION SITE ERYTHEMA |
16 |
0.0001 |
| 256 |
RENAL CYST |
1 |
0.0001 |
| 257 |
PREMATURE DELIVERY |
2 |
0.0001 |
| 258 |
BREAST CANCER STAGE II |
1 |
0.0001 |
| 259 |
SYNCOPE |
12 |
0.0001 |
| 260 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 261 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 262 |
METRORRHAGIA |
2 |
0.0001 |
| 263 |
ANURIA |
1 |
0.0001 |
| 264 |
PSYCHOLOGICAL TRAUMA |
1 |
0.0001 |
| 265 |
SYRINGE ISSUE |
2 |
0.0001 |
| 266 |
COLD SWEAT |
2 |
0.0001 |
| 267 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 268 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 269 |
ABDOMINAL PAIN |
26 |
0.0001 |
| 270 |
OVARIAN CANCER |
1 |
0.0001 |
| 271 |
CHEST DISCOMFORT |
11 |
0.0001 |
| 272 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 273 |
HYPONATRAEMIA |
6 |
0.0001 |
| 274 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 275 |
ATELECTASIS |
1 |
0.0001 |
| 276 |
POOR QUALITY DEVICE USED |
1 |
0.0001 |
| 277 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 278 |
DISCOMFORT |
6 |
0.0001 |
| 279 |
PERITONITIS |
2 |
0.0001 |
| 280 |
EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 281 |
UNEVALUABLE EVENT |
7 |
0.0001 |
| 282 |
NERVE INJURY |
1 |
0.0001 |
| 283 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 284 |
SHOCK |
2 |
0.0001 |
| 285 |
FOETAL EXPOSURE DURING PREGNANCY |
7 |
0.0001 |
| 286 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 287 |
URTICARIA |
14 |
0.0001 |
| 288 |
PRESYNCOPE |
2 |
0.0001 |
| 289 |
CONDITION AGGRAVATED |
25 |
0.0001 |
| 290 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 291 |
ABNORMAL WEIGHT GAIN |
1 |
0.0001 |
| 292 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 293 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 294 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 295 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 296 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 297 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 298 |
DEEP VEIN THROMBOSIS |
5 |
0.0001 |
| 299 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
2 |
0.0001 |
| 300 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 301 |
ADVERSE REACTION |
1 |
0.0001 |
| 302 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 303 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 304 |
DEVICE BREAKAGE |
3 |
0.0001 |
| 305 |
PULMONARY EMBOLISM |
7 |
0.0001 |
| 306 |
TACHYPNOEA |
1 |
0.0001 |
| 307 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 308 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 309 |
SKIN REACTION |
1 |
0.0001 |
| 310 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 311 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 312 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 313 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 314 |
DEVICE LEAKAGE |
3 |
0.0001 |
| 315 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 316 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 317 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 318 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 319 |
HYPERSENSITIVITY |
12 |
0.0001 |
| 320 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 321 |
SWELLING |
6 |
0.0001 |
| 322 |
LOSS OF CONSCIOUSNESS |
8 |
0.0001 |
| 323 |
VIRAL INFECTION |
2 |
0.0001 |
| 324 |
LIP SWELLING |
2 |
0.0001 |
| 325 |
TYPE 2 DIABETES MELLITUS |
2 |
0.0001 |
| 326 |
SCAR |
1 |
0.0001 |
| 327 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 328 |
DELIRIUM |
2 |
0.0001 |
| 329 |
MUSCULOSKELETAL PAIN |
3 |
0.0001 |
| 330 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 331 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 332 |
CRYING |
2 |
0.0001 |
| 333 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 334 |
DYSURIA |
2 |
0.0001 |
| 335 |
THINKING ABNORMAL |
1 |
0.0001 |
| 336 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 337 |
FOOT FRACTURE |
1 |
0.0001 |
| 338 |
PRODUCT USE IN UNAPPROVED INDICATION |
13 |
0.0001 |
| 339 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 340 |
CHOKING |
1 |
0.0001 |
| 341 |
HEART RATE INCREASED |
5 |
0.0001 |
| 342 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 343 |
INJECTION SITE HAEMORRHAGE |
4 |
0.0001 |
| 344 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 345 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 346 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 347 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 348 |
HAEMORRHAGE |
5 |
0.0000 |
| 349 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 350 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 351 |
ANGIOEDEMA |
2 |
0.0000 |
| 352 |
TACHYCARDIA |
4 |
0.0000 |
| 353 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 354 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 355 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 356 |
SLEEP DISORDER |
3 |
0.0000 |
| 357 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 358 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 359 |
DIPLOPIA |
1 |
0.0000 |
| 360 |
DIZZINESS |
19 |
0.0000 |
| 361 |
INJECTION SITE BRUISING |
3 |
0.0000 |
| 362 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 363 |
LIMB INJURY |
1 |
0.0000 |
| 364 |
RASH |
16 |
0.0000 |
| 365 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 366 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 367 |
HAEMOPTYSIS |
1 |
0.0000 |
| 368 |
FLATULENCE |
2 |
0.0000 |
| 369 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 370 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 371 |
HYPERSOMNIA |
1 |
0.0000 |
| 372 |
PALPITATIONS |
4 |
0.0000 |
| 373 |
DRUG INEFFECTIVE |
45 |
0.0000 |
| 374 |
CHILLS |
4 |
0.0000 |
| 375 |
SURGERY |
2 |
0.0000 |
| 376 |
VOMITING |
16 |
0.0000 |
| 377 |
PRURITUS |
13 |
0.0000 |
| 378 |
HEADACHE |
21 |
0.0000 |
| 379 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 380 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 381 |
OFF LABEL USE |
29 |
0.0000 |
| 382 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 383 |
EPILEPSY |
1 |
0.0000 |
| 384 |
MUSCLE SPASMS |
6 |
0.0000 |
| 385 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 386 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 387 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 388 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 389 |
MALAISE |
14 |
0.0000 |
| 390 |
PARAESTHESIA |
5 |
0.0000 |
| 391 |
CHOLELITHIASIS |
1 |
0.0000 |
| 392 |
NAUSEA |
24 |
0.0000 |
| 393 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 394 |
INJECTION SITE PAIN |
9 |
0.0000 |
| 395 |
INJECTION SITE REACTION |
2 |
0.0000 |
| 396 |
RASH MACULAR |
1 |
0.0000 |
| 397 |
DEVICE MALFUNCTION |
2 |
0.0000 |
| 398 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
5 |
0.0000 |
| 399 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 400 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 401 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 402 |
INJECTION SITE MASS |
1 |
0.0000 |
| 403 |
EYE SWELLING |
1 |
0.0000 |
| 404 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 405 |
DYSARTHRIA |
1 |
0.0000 |
| 406 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 407 |
HOT FLUSH |
2 |
0.0000 |
| 408 |
DYSPNOEA |
15 |
0.0000 |
| 409 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 410 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 411 |
SEIZURE |
3 |
0.0000 |
| 412 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 413 |
THROMBOSIS |
2 |
0.0000 |
| 414 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 415 |
BLINDNESS |
1 |
0.0000 |
| 416 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 417 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 418 |
TREATMENT FAILURE |
2 |
0.0000 |
| 419 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 420 |
CONSTIPATION |
5 |
0.0000 |
| 421 |
DEVICE ISSUE |
2 |
0.0000 |
| 422 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 423 |
SKIN IRRITATION |
1 |
0.0000 |
| 424 |
TINNITUS |
1 |
0.0000 |
| 425 |
HYPOKALAEMIA |
1 |
0.0000 |
| 426 |
ARRHYTHMIA |
1 |
0.0000 |
| 427 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 428 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 429 |
ANAEMIA |
4 |
0.0000 |
| 430 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 431 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 432 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 433 |
CONTUSION |
2 |
0.0000 |
| 434 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 435 |
HYPOTENSION |
4 |
0.0000 |
| 436 |
SINUSITIS |
2 |
0.0000 |
| 437 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 438 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 439 |
ERYTHEMA |
4 |
0.0000 |
| 440 |
INFLAMMATION |
1 |
0.0000 |
| 441 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 442 |
PANCREATITIS |
1 |
0.0000 |
| 443 |
HYPERTENSION |
4 |
0.0000 |
| 444 |
OVERDOSE |
4 |
0.0000 |
| 445 |
RASH PRURITIC |
1 |
0.0000 |
| 446 |
OEDEMA |
1 |
0.0000 |
| 447 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 448 |
ARTHROPATHY |
1 |
0.0000 |
| 449 |
SEPSIS |
2 |
0.0000 |
| 450 |
NECK PAIN |
1 |
0.0000 |
| 451 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 452 |
EYE PAIN |
1 |
0.0000 |
| 453 |
LETHARGY |
1 |
0.0000 |
| 454 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 455 |
FEELING ABNORMAL |
4 |
0.0000 |
| 456 |
IRRITABILITY |
1 |
0.0000 |
| 457 |
NO ADVERSE EVENT |
3 |
0.0000 |
| 458 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 459 |
VERTIGO |
1 |
0.0000 |
| 460 |
FEELING HOT |
1 |
0.0000 |
| 461 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 462 |
DEVICE EXPULSION |
1 |
0.0000 |
| 463 |
AMNESIA |
1 |
0.0000 |
| 464 |
SWELLING FACE |
1 |
0.0000 |
| 465 |
ALOPECIA |
3 |
0.0000 |
| 466 |
RENAL FAILURE |
2 |
0.0000 |
| 467 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 468 |
INSOMNIA |
4 |
0.0000 |
| 469 |
SOMNOLENCE |
3 |
0.0000 |
| 470 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 471 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 472 |
VISION BLURRED |
2 |
0.0000 |
| 473 |
BURNING SENSATION |
1 |
0.0000 |
| 474 |
FATIGUE |
11 |
0.0000 |
| 475 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 476 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 477 |
MOBILITY DECREASED |
1 |
0.0000 |
| 478 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 479 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 480 |
HYPOAESTHESIA |
2 |
0.0000 |
| 481 |
DIABETES MELLITUS |
1 |
0.0000 |
| 482 |
HOSPITALISATION |
2 |
0.0000 |
| 483 |
DECREASED APPETITE |
3 |
0.0000 |
| 484 |
TREMOR |
2 |
0.0000 |
| 485 |
PYREXIA |
4 |
0.0000 |
| 486 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 487 |
PAIN |
7 |
0.0000 |
| 488 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 489 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 490 |
DIARRHOEA |
7 |
0.0000 |
| 491 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 492 |
BREAST CANCER |
1 |
0.0000 |
| 493 |
COUGH |
3 |
0.0000 |
| 494 |
ASTHENIA |
4 |
0.0000 |
| 495 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 496 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 497 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 498 |
ARTHRALGIA |
4 |
0.0000 |
| 499 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 500 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 501 |
FALL |
3 |
0.0000 |
| 502 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 503 |
WEIGHT INCREASED |
2 |
0.0000 |
| 504 |
ASTHMA |
1 |
0.0000 |
| 505 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 506 |
DEPRESSION |
2 |
0.0000 |
| 507 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 508 |
BACK PAIN |
2 |
0.0000 |
| 509 |
JOINT SWELLING |
1 |
0.0000 |
| 510 |
HYPERHIDROSIS |
1 |
0.0000 |
| 511 |
PSORIASIS |
1 |
0.0000 |
| 512 |
DEHYDRATION |
1 |
0.0000 |
| 513 |
DRY SKIN |
1 |
0.0000 |
| 514 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 515 |
WEIGHT DECREASED |
2 |
0.0000 |
| 516 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 517 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 518 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 519 |
MYALGIA |
1 |
0.0000 |
| 520 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 521 |
COVID-19 |
1 |
0.0000 |
| 522 |
CHEST PAIN |
1 |
0.0000 |
| 523 |
ANXIETY |
1 |
0.0000 |
| 524 |
DEATH |
1 |
0.0000 |